» Articles » PMID: 1706625

Interferon-dependent Transcriptional Activation: Signal Transduction Without Second Messenger Involvement?

Overview
Journal New Biol
Date 1990 Oct 11
PMID 1706625
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Two specific macromolecular interactions are known to underlie the demonstrated transcriptional stimulation of different sets of genes incident to the binding of different polypeptide ligands to cells. The initial polypeptide-receptor interaction is widely recognized to be specific. It is also well established that the binding of specific transcription factors to well-defined DNA sites activates specific genes. In this paper, we suggest that a third, equally specific protein-protein interaction links the first two specific interactions and ensures the high specificity required in these pathways. We propose that a receptor-recognition protein is required to recognize the bound receptor. This receptor-recognition protein might itself be part of a transcription factor or might interact directly with a transcription factor that would thereby be activated and translocated to the nucleus to participate in gene activation. According to this hypothesis, no global changes in second messenger concentrations are necessary, and the enzymatic properties of the receptor-recognition protein(s) need not be specified. Phosphorylations of, or by, receptor-bound proteins would not, of course, be excluded. But such modifications during ligand-mediated signal transduction would not depend on global second messenger changes. This model is derived from studies of the proteins involved in interferon (IFN)-stimulated gene transcription. It is now established that interferon-alpha (IFN alpha) activates a multisubunit transcription factor in the cell cytoplasm, and that this factor then moves to the nucleus to activate a set of IFN-stimulated genes.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Helper T lymphocyte response in the peripheral blood of patients with intraepithelial neoplasia submitted to immunotherapy with pegylated interferon-α.

Michelin M, Montes L, Nomelini R, Trovo M, Murta E Int J Mol Sci. 2015; 16(3):5497-509.

PMID: 25764160 PMC: 4394488. DOI: 10.3390/ijms16035497.


An interferon response gene signature is associated with the therapeutic response of hepatitis C patients.

Pfeffer L, Li K, Fleckenstein J, Marion T, Diament J, Yang C PLoS One. 2014; 9(8):e104202.

PMID: 25111807 PMC: 4128657. DOI: 10.1371/journal.pone.0104202.


New function of type I IFN: induction of autophagy.

Schmeisser H, Bekisz J, Zoon K J Interferon Cytokine Res. 2014; 34(2):71-8.

PMID: 24428799 PMC: 3924851. DOI: 10.1089/jir.2013.0128.


Type I interferons induce autophagy in certain human cancer cell lines.

Schmeisser H, Fey S, Horowitz J, Fischer E, Balinsky C, Miyake K Autophagy. 2013; 9(5):683-96.

PMID: 23419269 PMC: 3669179. DOI: 10.4161/auto.23921.


The JAK-STAT pathway at twenty.

Stark G, Darnell Jr J Immunity. 2012; 36(4):503-14.

PMID: 22520844 PMC: 3909993. DOI: 10.1016/j.immuni.2012.03.013.